About Syntex: Our Growth

Syntex continued growing is based on the permanent search of cientific progresses and therefore excellence products. This vocation of permanent innovation has determined a way of great success..

1945 Estrone production.
1950 Estradiol Benzoate production.
1961 Large scale Heparin production.
1978 eCG (PMSG) production.
1982 Large scale Chondroitin Sulphate production.
1984 Ferric Proteins production (natural and semi-synthetic).
1986 Development of Heparin semi-synthetic polysaccharide derivatives. First depolymerization studies.
1987 Suleparoide (INN) production, first semi-synthetic polysaccharide. Technological development under patent.
1989 Approval as veterinary products manufacturer.
1990 Low Molecular Weight Heparin. Technological development under patent.
1991 Veterinary products first registation . Novormon.
1992 Semi-synthetic Heparin, Dermatan and Chondroitin Sulphate derivatives and analogues.
1994 Beginning of Syntex veterinary products trading activities.
1996 Low Molecular Weight Chondroitin Sulphate industrial production.
2001 Low Molecular Weight Chondroitin Sulphate Triethanolamine Salt production and Low Molecular Weight Heparin industrial production.
2004 Patenting of Modified Heparin new fragments for topic administration in antithrombotic use.
2005 Opening of Bovine Intravaginal Device new manufacturing plant.
2006 Opening of Heparin new plant. Attainment of Chondroitin Sulphate Certificate of Suitability.
2008 Low Molecular Weight Heparin (Parnaparin) plant approval by the Japanese Health Regulatory Authority.
2010 Opening of the new plant of Injectable Veterinary Specialties.
2010 Bovine Intravaginal Device registration in Japan.

1996 - Development of Heparin semi-synthetic polysaccharide derivatives. First depolymerization studies.

1994 - Beginning of Syntex veterinary products trading activities.
2006 - Opening of
Heparin new plant

2010 - Bovine Intravaginal Device registration in Japan..

Syntex is an Argentine company with worldwide vision that succeeded in its strengthening through the integration of their processes. Several active ingredients manufactured in the pharmo-chemical plant are used as raw materials in the production of veterinary products.